1145P Clinical characteristics and survival of patients with advanced Merkel cell carcinoma (MCC) treated with avelumab: Analysis of a prospective German MCC registry (MCC TRIM)Jürgen C. Becker, S. Ugurel-Becker, Saeed Mahmoudpour et al.|Annals of Oncology|2023Cited by 3
LBA45 Early switch from targeted to immunotherapy in advanced BRAFV600-positive melanoma: Long-term OS and final PFS results of the randomized phase II ImmunoCobiVem trialD. Schadendorf, E. Livingstone, Rudolf Herbst et al.|Annals of Oncology|2024Cited by 3
1168P Tumor PD-L1 predicts the outcome of PD-1-based immunotherapy in metastatic melanoma depending on the type of tissue examinedJ-M. Placke, S. Ugurel-Becker, Martin Kimmig et al.|Annals of Oncology|2023Cited by 1
1133P Only early adjuvant radiotherapy, particularly of the tumor bed rather than the lymph node region, improves prognosis in Merkel cell carcinoma: Results from the prospective German MCC registryJürgen C. Becker, Georg Lodde, U. Leiter-Stoppke et al.|Annals of Oncology|2024Cited by 0